Affiliation:
1. Russian Research Institute for Plague Control «Microbe»
Abstract
Live genetic engineering anthrax vaccines on the platform of avirulent and probiotic micro-ogranisms are a safe and adequate alternative to preparations based on attenuated Bacillus anthracis strains. Mucosal application results in a direct contact of the vaccine preparations with mucous membranes in those organs and tissues of the macro-organisms, that are exposed to the pathogen in the first place, resulting in a development of local and systemic immune response. Live recombinant anthrax vaccines could be used both separately as well as in a prime-boost immunization scheme. The review focuses on immunogenic and protective properties of experimental live genetic engineering preparations, created based on members ofgeni of Salmonella, Lactobacillus and adenoviruses.
Publisher
Central Research Institute for Epidemiology
Reference54 articles.
1. Mikshis N.I., Popova P.Yu., Kudryavtseva O.M., Semakova A.P., Novikova L.V., Kravtsov A.L., Bugorkova S.A., Shchukovskaya T.N., Popov Yu.A., Kutyrev V.V. Immunogennost' i bezopasnost' prototipa khimicheskoi sibireyazvennoi vaktsiny na modeli laboratornykh zhivotnykh. Zhurn. mikrobiol. 2014, 4: 22-30.
2. Abboud N., Casadevall A. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background. Clin. Vaccine Immunol. 2008, 15 (7): 1115-1123.
3. Alcock R., Cottingham M., Rollier C. et al. Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass. Sci. Transl. Med. 2010, 2: 19ra12.
4. Alemayehu D., Utt E., Knirsch C. Vaccines: A review of immune-based interventions to prevent and treat disease. J. Clinical Pharmacology. 2015, 55 (S3): S93-S102.
5. Baillie L., Rodriguez A., Moore S. et al. Towards a human oral vaccine for anthrax: the utility of a Salmonella typhi Ty21a-based prime boost immunization strategy. Vaccine. 2008, 26 (48): 6083-6091.